This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Wyeth Holdings Corporation. Active years: 2004-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2009
Title: The Innovative Contributions of Timothy Joseph Zamb
Introduction
Timothy Joseph Zamb is a notable inventor based in Nyack, NY (US). He has made significant contributions to the field of immunology and virology, holding a total of 3 patents. His work focuses on developing innovative methods and compositions for immunization against various viruses.
Latest Patents
Zamb's latest patents include groundbreaking inventions such as "Fusogenic, self-propagating blebs as immunogenic compositions." This invention involves the production of self-propagating, fusogenic blebs from cells infected with Venezuelan Equine Encephalitis virus replicon particles. These blebs are utilized to create immunogenic compositions aimed at immunizing mammals against paramyxoviruses, including parainfluenza virus type 3. Another significant patent is related to "Packaging of positive-strand RNA virus replicon particles." This invention encompasses recombinant polynucleotides and packaging systems that facilitate the generation of psRNAV replicon particles, which are crucial for developing pharmaceutical formulations and generating immune responses.
Career Highlights
Timothy Zamb is currently associated with Wyeth Holdings Corporation, where he continues to advance his research and innovations. His work has been instrumental in the development of new immunological strategies and pharmaceutical applications.
Collaborations
Zamb has collaborated with esteemed colleagues such as Gerald R Kovacs and Stephen Alexander Udem, contributing to a rich environment of innovation and research.
Conclusion
Timothy Joseph Zamb's contributions to the field of immunology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in immunogenic compositions and viral research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile